OncologyOncoSurveyNCT05437354
Online Survey: Oncologists' Thoughts Regarding Their Patients
An observational study of Oncology, run by Cairo University at 1 site in Egypt.
Trial summary
Our study is a questionnaire targeting the medical staff in Oncology. It aims at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It also investigates the factors that affect these thoughts and expectations and their effects. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Oncology
- What is being tested?
- survey
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 20 Jun 2022to 1 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Any Medical staff in Oncology Field worldwide, with no age limit
Who may be able to join
- Medical/Clinical/Radiation Oncology Physicians
- Surgical Oncology Physicians
- Oncology nurses
Who cannot join
- Medical staff not related to oncology field
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Oncologists' Thoughts and Expectations Regarding Their Patients. An Online Survey
Our study is a questionnaire targeting the medical staff in Oncology. It aims at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It also investigates the factors that affect these thoughts and expectations and their effects.
Read the detailed description
Oncology patients need to trust the medical staff dealing with them. They are expecting knowledge, well communication, competence .. etc. This Questionnaire is for research purpose aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It investigates the factors that affect these thoughts and expectations and their effects. The results of this survey will shed the light on the oncologists' side of their relationship with their patients, which is often ignored or down played.
- Conditions
- Oncology
- Being tested
- survey
- Keywords
- Oncologists, Survey, Expectations
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
surveyOther
Oncology medical staff should respond to a survey
What is being measured
The primary outcome is the main question the study is designed to answer.
What are the most and least important factors the oncologists usually consider when they build their management plan?
We would like to know the factors that the oncologists usually consider for a patient's management plan. This will be done via a questionnaire.
Measured: Two months
Secondary outcomes (3)
How often do oncologists inform patients of the detailed management plan? and Why?
We would like to know if the oncologists inform the patients the detailed management plan. and if they are expecting patients to fully understand the plan. This will be done via a questionnaire.
Measured: Two months
How satisfied do oncologists think most patients are during their management.
we would like to know how satisfied are the patients during their management, and why they are unsatisfied from the oncologists point of view. This will be done via a questionnaire.
Measured: Two months
How often are Oncology patients open to their case being discussed in multidisciplinary clinics or being referred to psychiatrists/Nutritionists/palliative care/hospice?
This will be done via a questionnaire to see their point of view.
Measured: Two months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2022
- Study start20 Jun 2022
- Primary completion1 Oct 2022
- Study completion1 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OncologyStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Riham H. AbdelAziz, Cairo University
- Investigators
- Riham AbdelAziz, MD/PhD, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05437354
- Sponsor's protocol ID
- OncoSurvey2
- Acronym
- OncoSurvey
- Status last verified
- Oct 2022
- First submitted
- 17 Jun 2022
- Last updated
- 4 Oct 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The questionnaire is aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It would be published after its completeion
Study at a glance
From the registry record, last updated by the sponsor on 4 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oncologists' Thoughts and Expectations Regarding Their Patients. An Online Survey
- ClinicalTrials.gov ID
- NCT05437354
- Acronym / sponsor ID
- OncoSurvey / OncoSurvey2
- Conditions
- Oncology
- Keywords
- Oncologists, Survey, Expectations
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 500 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 20 Jun 2022 (actual)
- Primary completion
- 1 Oct 2022 (actual)
- Study completion
- 1 Oct 2022 (actual)
- First posted
- 29 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our study is a questionnaire targeting the medical staff in Oncology. It aims at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It also investigates the factors that affect these thoughts and expectations and their effects.
Detailed description
Oncology patients need to trust the medical staff dealing with them. They are expecting knowledge, well communication, competence .. etc. This Questionnaire is for research purpose aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It investigates the factors that affect these thoughts and expectations and their effects. The results of this survey will shed the light on the oncologists' side of their relationship with their patients, which is often ignored or down played.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Any Medical staff in Oncology Field worldwide, with no age limit
Key inclusion criteria (3 listed)
- Medical/Clinical/Radiation Oncology Physicians
- Surgical Oncology Physicians
- Oncology nurses
Key exclusion criteria (1 listed)
- Medical staff not related to oncology field
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| surveyOncology medical staff should respond to a survey | Other | – |
Primary outcome
What are the most and least important factors the oncologists usually consider when they build their management plan?
Time frame: Two months
We would like to know the factors that the oncologists usually consider for a patient's management plan. This will be done via a questionnaire.
3 secondary outcomes
How often do oncologists inform patients of the detailed management plan? and Why?
Time frame: Two months
How satisfied do oncologists think most patients are during their management.
Time frame: Two months
How often are Oncology patients open to their case being discussed in multidisciplinary clinics or being referred to psychiatrists/Nutritionists/palliative care/hospice?
Time frame: Two months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Oct 2022.
- Individual participant dataSharing planned: Undecided. The questionnaire is aiming at exploring the thoughts and expectations of the medical staff in Oncology regarding their patients management and prognosis worldwide. It would be published after its completeion
Related trials for Oncology
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Riham AbdelAziz, MD/PhD principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Oncology, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
What are the most and least important factors the oncologists usually consider when they build their management plan? (time frame: Two months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022.